![Marino Garcia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marino Garcia
Vorstandsvorsitzender bei
DIANTHUS THERAPEUTICS, INC.
Vermögen: 6 Mio $ am 30.09.2026
Profil
Mr. Marino Garcia is a President, Chief Executive Officer & Director at Dianthus Therapeutics, Inc. and a President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. He is on the Board of Directors at AgomAb Therapeutics NV, Dianthus Therapeutics, Inc. and Dianthus Therapeutics OpCo, Inc. Mr. Garcia was previously employed as a Senior VP-Corporate & Business Development by Zealand Pharma A/S, a Chief Strategy Officer & Executive Vice President by Synergy Pharmaceuticals, Inc., a Vice President-Business Development by Aptalis Pharma Canada,Inc., and a Vice President-US Commercial Operations by Aspreva Pharmaceuticals Corp.
He received his undergraduate degree from Concordia University and an MBA from Richard Ivey School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.08.2026 | 65.292 ( 0,2 % ) | 6 Mio $ | 30.09.2026 |
Aktive Positionen von Marino Garcia
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Vorstandsvorsitzender | 11.09.2023 |
| AGOMAB THERAPEUTICS NV | Direktor/Vorstandsmitglied | 11.09.2026 |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Vorstandsvorsitzender | 01.11.2021 |
Ehemalige bekannte Positionen von Marino Garcia
| Unternehmen | Position | Ende |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | 01.10.2021 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 30.09.2018 |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 13.03.2014 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Marino Garcia
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
